Selected research
Industry Research
Combined Hormonal Contraceptives Industry Research Report 2026
Market perspective
The global Combined Hormonal Contraceptives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Combined Hormonal Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Combined Hormonal Contraceptives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Combined Hormonal Contraceptives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Combined Hormonal Contraceptives include Teva Pharmaceutical Industries, Johnson & Johnson, Mylan, Bayer, Ortho-McNeil-Janssen Pharmaceuticals, Noven Pharmaceuticals, ANI Pharmaceuticals, Allergan and Agile Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Combined Hormonal Contraceptives market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Combined Hormonal Contraceptives Market by Company
Teva Pharmaceutical Industries
Johnson & Johnson
Mylan
Bayer
Ortho-McNeil-Janssen Pharmaceuticals
Noven Pharmaceuticals
ANI Pharmaceuticals
Allergan
Agile Therapeutics
Actavis
Combined Hormonal Contraceptives Segment by Type
Above 44 years
35-44 years
25-34 years
15-24 years
Combined Hormonal Contraceptives Segment by Application
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Combined Hormonal Contraceptives Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Combined Hormonal Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Combined Hormonal Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Combined Hormonal Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Combined Hormonal Contraceptives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Combined Hormonal Contraceptives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Combined Hormonal Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 44 years
- 35-44 years
- 25-34 years
- 15-24 years
Applications
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
Companies covered
- Teva Pharmaceutical Industries
- Johnson & Johnson
- Mylan
- Bayer
- Ortho-McNeil-Janssen Pharmaceuticals
- Noven Pharmaceuticals
- ANI Pharmaceuticals
- Allergan
- Agile Therapeutics
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Combined Hormonal Contraceptives Market Size (2021-2032)
- 2.2.2 Global Combined Hormonal Contraceptives Sales (2021-2032)
- 2.2.3 Global Combined Hormonal Contraceptives Market Average Price (2021-2032)
- 2.3 Combined Hormonal Contraceptives by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Above 44 years
- 2.3.3 35-44 years
- 2.3.4 25-34 years
- 2.3.5 15-24 years
- 2.4 Combined Hormonal Contraceptives by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Hospital Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Combined Hormonal Contraceptives Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Combined Hormonal Contraceptives Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Combined Hormonal Contraceptives Revenue of Manufacturers (2021-2026)
- 3.4 Global Combined Hormonal Contraceptives Average Price by Manufacturers (2021-2026)
- 3.5 Global Combined Hormonal Contraceptives Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Combined Hormonal Contraceptives, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Combined Hormonal Contraceptives, Product Type & Application
- 3.8 Global Manufacturers of Combined Hormonal Contraceptives, Established Date
- 3.9 Global Combined Hormonal Contraceptives Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries
- 4.1.1 Teva Pharmaceutical Industries Company Information
- 4.1.2 Teva Pharmaceutical Industries Business Overview
- 4.1.3 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Combined Hormonal Contraceptives Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Combined Hormonal Contraceptives Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Bayer
- 4.4.1 Bayer Company Information
- 4.4.2 Bayer Business Overview
- 4.4.3 Bayer Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer Combined Hormonal Contraceptives Product Portfolio
- 4.4.5 Bayer Recent Developments
- 4.5 Ortho-McNeil-Janssen Pharmaceuticals
- 4.5.1 Ortho-McNeil-Janssen Pharmaceuticals Company Information
- 4.5.2 Ortho-McNeil-Janssen Pharmaceuticals Business Overview
- 4.5.3 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
- 4.5.5 Ortho-McNeil-Janssen Pharmaceuticals Recent Developments
- 4.6 Noven Pharmaceuticals
- 4.6.1 Noven Pharmaceuticals Company Information
- 4.6.2 Noven Pharmaceuticals Business Overview
- 4.6.3 Noven Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Noven Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
- 4.6.5 Noven Pharmaceuticals Recent Developments
- 4.7 ANI Pharmaceuticals
- 4.7.1 ANI Pharmaceuticals Company Information
- 4.7.2 ANI Pharmaceuticals Business Overview
- 4.7.3 ANI Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ANI Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
- 4.7.5 ANI Pharmaceuticals Recent Developments
- 4.8 Allergan
- 4.8.1 Allergan Company Information
- 4.8.2 Allergan Business Overview
- 4.8.3 Allergan Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Allergan Combined Hormonal Contraceptives Product Portfolio
- 4.8.5 Allergan Recent Developments
- 4.9 Agile Therapeutics
- 4.9.1 Agile Therapeutics Company Information
- 4.9.2 Agile Therapeutics Business Overview
- 4.9.3 Agile Therapeutics Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Agile Therapeutics Combined Hormonal Contraceptives Product Portfolio
- 4.9.5 Agile Therapeutics Recent Developments
- 4.10 Actavis
- 4.10.1 Actavis Company Information
- 4.10.2 Actavis Business Overview
- 4.10.3 Actavis Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Actavis Combined Hormonal Contraceptives Product Portfolio
- 4.10.5 Actavis Recent Developments
5 Global Combined Hormonal Contraceptives Market Scenario by Region
- 5.1 Global Combined Hormonal Contraceptives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Combined Hormonal Contraceptives Sales by Region: 2021-2032
- 5.2.1 Global Combined Hormonal Contraceptives Sales by Region: 2021-2026
- 5.2.2 Global Combined Hormonal Contraceptives Sales by Region: 2027-2032
- 5.3 Global Combined Hormonal Contraceptives Revenue by Region: 2021-2032
- 5.3.1 Global Combined Hormonal Contraceptives Revenue by Region: 2021-2026
- 5.3.2 Global Combined Hormonal Contraceptives Revenue by Region: 2027-2032
- 5.4 North America Combined Hormonal Contraceptives Market Facts & Figures by Country
- 5.4.1 North America Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Combined Hormonal Contraceptives Sales by Country (2021-2032)
- 5.4.3 North America Combined Hormonal Contraceptives Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Combined Hormonal Contraceptives Market Facts & Figures by Country
- 5.5.1 Europe Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Combined Hormonal Contraceptives Sales by Country (2021-2032)
- 5.5.3 Europe Combined Hormonal Contraceptives Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Combined Hormonal Contraceptives Market Facts & Figures by Country
- 5.6.1 Asia Pacific Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Combined Hormonal Contraceptives Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Combined Hormonal Contraceptives Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Combined Hormonal Contraceptives Market Facts & Figures by Country
- 5.7.1 South America Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Combined Hormonal Contraceptives Sales by Country (2021-2032)
- 5.7.3 South America Combined Hormonal Contraceptives Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Combined Hormonal Contraceptives Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Combined Hormonal Contraceptives Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Combined Hormonal Contraceptives Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Combined Hormonal Contraceptives Sales by Type (2021-2032)
- 6.1.1 Global Combined Hormonal Contraceptives Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Combined Hormonal Contraceptives Sales Market Share by Type (2021-2032)
- 6.2 Global Combined Hormonal Contraceptives Revenue by Type (2021-2032)
- 6.2.1 Global Combined Hormonal Contraceptives Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Combined Hormonal Contraceptives Revenue Market Share by Type (2021-2032)
- 6.3 Global Combined Hormonal Contraceptives Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Combined Hormonal Contraceptives Sales by Application (2021-2032)
- 7.1.1 Global Combined Hormonal Contraceptives Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Combined Hormonal Contraceptives Sales Market Share by Application (2021-2032)
- 7.2 Global Combined Hormonal Contraceptives Revenue by Application (2021-2032)
- 7.2.1 Global Combined Hormonal Contraceptives Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Combined Hormonal Contraceptives Revenue Market Share by Application (2021-2032)
- 7.3 Global Combined Hormonal Contraceptives Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Combined Hormonal Contraceptives Value Chain Analysis
- 8.1.1 Combined Hormonal Contraceptives Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Combined Hormonal Contraceptives Production Mode & Process
- 8.2 Combined Hormonal Contraceptives Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Combined Hormonal Contraceptives Distributors
- 8.2.3 Combined Hormonal Contraceptives Customers
9 Global Combined Hormonal Contraceptives Analyzing Market Dynamics
- 9.1 Combined Hormonal Contraceptives Industry Trends
- 9.2 Combined Hormonal Contraceptives Industry Drivers
- 9.3 Combined Hormonal Contraceptives Industry Opportunities and Challenges
- 9.4 Combined Hormonal Contraceptives Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst